CIK 0001994702 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Kyverna Therapeutics, Inc.
Sign in to watch- Ticker
- KYTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831365441
- Phone
- 5109252492
- Business address
- 5980 HORTON STREET, SUITE 200, EMERYVILLE, CA
- Former names
- Kyverna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | SEIDENBERG BETH C Director | Conversion · Series B Redeemable Convertible Preferred Stock | −3,349,538 | 0 | ||
| 2024-02-12 | Bain Capital Life Sciences Investors, LLC 10% owner | Conversion | +2,713,868 | 2,713,868 | ||
| 2024-02-12 | Bain Capital Life Sciences Investors, LLC 10% owner | Purchase | +450,000 | $22.00 | $9.9M | 3,163,868 |
| 2024-02-12 | Bain Capital Life Sciences Investors, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −12,351,087 | 0 | ||
| 2024-02-12 | GILEAD SCIENCES, INC. 10% owner | Conversion | +3,216,119 | 3,216,119 | ||
| 2024-02-12 | GILEAD SCIENCES, INC. 10% owner | Purchase | +910,000 | $22.00 | $20.0M | 4,126,119 |
| 2024-02-12 | GILEAD SCIENCES, INC. 10% owner | Conversion · Series A-2 Convertible Preferred Stock | −6,890,744 | 0 | ||
| 2024-02-12 | GILEAD SCIENCES, INC. 10% owner | Conversion · Series B Convertible Preferred Stock | −7,746,139 | 0 | ||
| 2024-02-12 | Northpond Ventures III GP, LLC Former 10% Owner | Conversion | +2,805,426 | 2,805,426 | ||
| 2024-02-12 | Northpond Ventures III GP, LLC Former 10% Owner | Purchase | +450,000 | $22.00 | $9.9M | 450,000 |
| 2024-02-12 | Northpond Ventures III GP, LLC Former 10% Owner | Conversion · Series B Preferred Stock | −12,767,776 | 0 |
Page 5 of 5 · 91 trades